Artis Biosolutions
1 known investors
Find your way into Artis Biosolutions
Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
Founders & leadership
Investors · 1
Competitors · 3
by search overlap
Fortis Life Sciences13 shared keywordsFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
IQVIA7 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Eli Lilly7 shared keywordsEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.
Companies competing with Artis Biosolutions for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Artis Biosolutions do?
- Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.
- Who are Artis Biosolutions's investors?
- Artis Biosolutions's investors include Oak HC/FT.